The abstract is read at the publisher; the summary is JClub's.
Platelet-biased, Vwf-positive hematopoietic stem cells initiate CALR-mutated myeloproliferative neoplasms, with CALRdel52 showing selective Vwf-positive HSC amplification linked to PERK/eIF2a signaling.
- Why it matters: The disease-initiating HSC identity and how CALR clones expand are unclear, limiting targeted strategies for MPNs driven by calreticulin mutations.
- What they did: CALRdel52 and CALRins5 knock-in mice were crossed with Vwf-GFP reporter mice to track HSC subsets, then PERK/eIF2a activity was tested using eIF2a phosphorylation and PERK inhibition.
- The result: PERK inhibition markedly reduces proliferation of mouse CALRdel52 HSCs and impairs megakaryocytic differentiation of CALRdel52-like patient HSPCs while sparing healthy donor cells, supporting PERK/eIF2a as a vulnerability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.